-
-
As the new kid on the OB/GYN Clinical Alert block, and as the generalist among the editors, I intend to focus on topics that come up commonly in my own practice of obstetrics and gynecology. The beauty of having this format is that cutting edge science can be presented, but also sacred cows can be challenged.
-
In December, a group from Austria published a report evaluating outcomes of infants presenting at term with breeches whose mothers were scheduled to have either an elective cesarean section or a planned vaginal birth.
-
-
There are various morphine products available to treat moderate-to-severe chronic pain. The following facts are provided to differentiate among three sustained-release products that are currently available.
-
The purpose of this article is to review the standard therapy for Pulmonary arterial hypertension (PAH) as well as to discuss the new therapies that recently have been approved by the U.S. Food and Drug Administration (FDA) for managing this disease state.
-
Intravenous immunoglobulin (IVIG) is safe and effective therapy for acute exacerbations of myasthenia gravis (MG), myasthenic crisis, and for optimizing patients conditions in preparation for thymectomy. Its role in the long-term management of MG remains to be defined.
-
Among patients with coronary artery disease, HMG CoA reductase inhibitors (statins) are a mainstay of therapy. These drugs have also become widely prescribed with a low threshold to patients with elevated cholesterol and even minimal cardiac risk factors.
-
Within minutes of an acute cerebral ischemic insult, diffusion-weighted magnetic resonance imaging (DWI) demonstrates ischemic regions with a decline in the apparent diffusion coefficient (ADC) of water. ADC decline is associated with impaired high-energy metabolism and loss of ion homeostasis. Animal studies and preliminary observations in humans demonstrate that initial DWI and ADC abnormalities are reversible by early reperfusion.
-